Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

132
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
132
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

92
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
92
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

559
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
559
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

667
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
667

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

C5b-9 Deposition in Renal Transplant Biopsies Associates With Prolonged Delayed Graft Function in Kidneys Donated After Circulatory Death.

Transplantation·2026
Same author

Urinary NGAL Outperforms <sup>99m</sup>Tc-MAG3 Renography in Predicting DCD Kidney Graft Function.

Transplant international : official journal of the European Society for Organ Transplantation·2025
Same author

Belgian Consensus Guidelines Within Eurotransplant on Imlifidase-enabled Deceased Donor Kidney Transplantation in Highly Sensitized Patients.

Transplantation·2025
Same author

Predicting Kidney Outcomes in Autosomal Dominant Polycystic Kidney Disease: A Comprehensive Biomarker Analysis.

Clinical journal of the American Society of Nephrology : CJASN·2025
Same author

Prospective Study on Individualized Dose Adjustment of Tolvaptan Based on Urinary Osmolality in Patients With ADPKD.

Kidney international reports·2025
Same author

Allogeneic mesenchymal stromal cell therapy in kidney transplantation: should repeated human leukocyte antigen mismatches be avoided?

Frontiers in genetics·2024

相关实验视频

Updated: Jul 8, 2025

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

52.3K

血清胆汁酸与多囊性肝病的肝体积有关,在用兰胺治疗后会减少.

Shosha E I Dekker1, Jörgen Bierau2, Martin Giera3

  • 1Department of Nephrology, Leiden University Medical Center, Leiden, the Netherlands.

European journal of clinical investigation
|December 10, 2023
PubMed
概括

在具有多囊性肝病 (PLD) 的自体主导性多囊性病 (ADPKD) 中,血清胆酸与肝脏大小相关. 在这些患者中,lanreotide治疗降低了胆酸,但并没有降低肝脏体积.

关键词:
在 ADPKDD 中,在PLD PLD中使用.胆酸胆酸是一种胆酸.生物标志物生物标志物

更多相关视频

A Silver Nanoparticle Method for Ameliorating Biliary Atresia Syndrome in Mice
07:48

A Silver Nanoparticle Method for Ameliorating Biliary Atresia Syndrome in Mice

Published on: October 13, 2018

7.7K
A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia
09:12

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia

Published on: February 3, 2023

2.5K

相关实验视频

Last Updated: Jul 8, 2025

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

52.3K
A Silver Nanoparticle Method for Ameliorating Biliary Atresia Syndrome in Mice
07:48

A Silver Nanoparticle Method for Ameliorating Biliary Atresia Syndrome in Mice

Published on: October 13, 2018

7.7K
A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia
09:12

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia

Published on: February 3, 2023

2.5K

科学领域:

  • 肝病学 肝病学是一种肝病学.
  • 腎臟病學 (nephrology) 是一種醫學專業.
  • 生物化学 生物化学

背景情况:

  • 多囊性肝病 (PLD) 是自身主导性多囊性病 (ADPKD) 的常见并发症.
  • 胆酸与PLD的病变产生有关.
  • 这项研究调查了有或没有PLD的ADPKD患者的胆酸概况.

研究的目的:

  • 为了确定血清胆汁酸水平是否在患有PLD的ADPKD患者中升高.
  • 评估lanreotide对PLD中的胆酸水平的影响.
  • 探索尿胆酸分泌在PLD中病进展中的作用.

主要方法:

  • 血清和尿液胆汁酸的量化使用液体染色学-质谱学.
  • 对105名PLD ADPKD患者与52名非PLD ADPKD对照进行了比较.
  • 在基线和经过120周的lanreotide或标准护理后分析样本.

主要成果:

  • 在肝脏较大的患者中观察到较高的结合胆酸血清基线水平.
  • 在PLD患者中,兰胺治疗导致多重血清胆酸的减少.
  • 没有发现尿液胆汁酸水平的显著变化或与病进展的相关性.

结论:

  • 患有PLD的ADPKD患者的血清胆酸水平与肝脏体积有关.
  • 兰胺有效降低血清胆汁酸水平,独立于肝体积的变化.
  • 尿液胆汁酸分泌似乎不会导致脏疾病在这个队列的进展.